Table 7. Demographics, indication for surgery, radiologic data and outcome in systematic review.
Pts | M/F | Age (years) | CRLM | CCA | FLR (%) increase | R0 | Morbidity | Mortality | Interval between 2 steps (days) | Hospital duration(days) | |
---|---|---|---|---|---|---|---|---|---|---|---|
Schnitzbauer, 2012[4] | 25 | 14/11 | 63 (32–75) | 11 (44%) | 4 (16%) | 74 (21–192) | 96% | 64% | 12% | NA | NA |
Alvarez, 2013[22] | 15 | 9/6 | 54 | 10 (66.7%) | 1 (6.7%) | 78.4 | 100% | 53% | 0% | NA | 19 |
Brustia, 2013[24] | 6 | NA | NA | 4 (66.7%) | 0 | 43 | NA | NA | NA | 8 | NA |
Björnsson, 2013[23] | 2 | 2/0 | 77–80 | 1 (50%) | 0 | 106 | 100% | 0% | NA | 9–7 | 10 |
Torres, 2013[35] | 39 | 22/17 | 57.3 (20–83) | 32 (82%) | 3 (7.7%) | 83 (47–211.9) | NA | 59.0% | 12.8 | 14.1 (5–30) | 17.8 (13–40) |
Knoefel, 2013[28] | 7 | NA | NA | 4 (57%) | NA | 63 (29) | NA | 71.4% | NA | 6 (4–8) | NA |
Ielpo, 2013[27] | 6 | 2/4 | 59.2 (56–63) | 5 (83.3%) | 1 (16.7%) | 110 | NA | 100% | 16.7% | 16 (12–21) | 34.2 |
Li, 2013[29] | 9 | 4/5 | NA | 3 (33.3%) | 6 (66.7%) | 87.2 (23.8–161) | NA | NA | NA | 13 (9–18) | NA |
Hernandez, 2014[26] | 14 | 9/5 | 57 (31–66) | 14 (100%) | 0 | 93±28 | 86% | 36% | NA | 8±1 | 23±12 |
Oldhafer, 2014[31] | 7 | 4/3 | 65.7 | 7 (100%) | 0 | 65 (16–97) | 100% | NA | NA | 13 (10–40) | NA |
Troja, 2014[36] | 5 | 4/1 | 59.6 | 2 (40%) | 1 (20%) | NA | 100% | 100% | 20% | NA | 56.7 |
Robles, 2014[33] | 22 | 17/5 | 65 (35–80) | 17 (77.3%) | 0 | 61 (33–189) | NA | 63.6% | 9.1% | 11 (8–28) | 16 (12–28) |
Schadde, 2014[34] | 48 | NA | NA | 26 (54.2%) | 10 (20.8%) | 77 | NA | NA | 15% | NA | NA |
Nadalin, 2014[30] | 15 | 7/8 | 67 (43–80) | 5 (33.3%) | 9 (60%) | 87.2 (23.8−161) | 86.7% | 66.7% | 28.7% | 13 (9−18) | NA |
Vennarecci, 2014[37] | 3 | NA | 58.3 | 0 | 0 | 31.7 | NA | 100% | 0% | NA | 21 |
Ratti, 2014[32] | 6 | 4/2 | 62.5 | 3 (50%) | 2 (33.3%) | 62.2 | 100% | 66.7% | 0% | NA | NA |
De Carlis, 2014[25] | 3 | 2/1 | 66.7 (59–76) | 2 (66.7%) | 1 (33.3%) | 57.4 (33.2–79.1) | NA | NA | NA | NA | NA |
Croome, 2015[39] | 15 | 11/4 | 55.9±12.1 | 14 (93%) | 0 | 36.1±6.4 | NA | NA | 0% | 7.8±1.1 | NA |
Herman, 2015[40] | 7 | 5/2 | 52.4±7.39 | 6 (85.7%) | 1 | 68.7±15.9 | NA | 57.1% | 0% | 8.1±2.6 | 20.4 (13–38) |
Tanaka, 2015[41] | 10 | 7 (64%) | 68 (50–78) | 10 (91%) | 0 | 52.9 | 100% | 7 (63.6%) | 1 (9%) | NA | 11.0 (8–54) |
Truant, 2015[42] | 62 | 45 (72.6%) | 59.1±9.3 | 50 (80.6%) | 3 (4.8%) | 48.6 (-15.3–192) | NA | 50 (80.6%) | 8 (12.9%) | 7.8±4.5 | 29.2±24.1 |
Present series, 2015 | 9 | 2/7 | 60±8 | 4 (44.4%) | 4 (44.4%) | 96 (44–160) | 100% | 67% | 11.1% | 11 (7–15) | 22 (13–55) |
ALPPS registry[38] | 202 | 121/81 | 60 | 141 (70%) | 19 (9.4%) | 80 | NA | NA | 9% | NA | 20 |
NA: not available.